### Analysis

- **Company Performance vs. Expectations**: Johnson & Johnson delivered strong financial results in Q1 2024, with sales of $21.4 billion and earnings per share of $2.20, exceeding expectations.
- **Management Tone**: Management was optimistic about the company's performance and future growth prospects, highlighting strong pipeline progress and strategic acquisitions.
- **Guidance Updates**: The company provided adjusted full-year guidance, tightening the operational sales and EPS ranges to reflect strong Q1 performance.
- **External/Macro Influences**: The company did not provide specific commentary on macroeconomic conditions or geopolitical risks.

### Conclusion

The short-term (1â€“2 weeks) impact on Johnson & Johnson's stock price is expected to be **positive**. The company's strong Q1 results, pipeline advancements, and strategic acquisitions will likely boost investor confidence, leading to a positive reaction in the stock price.

### Rating

1